// App-Quantinova.ai

223 : Patient organisation-led initiatives can play an important role in raising awareness about Raynaud’s phenomenon and encourage earlier healthcare utilisation for high risk groups

Researchers

Presenter

  • Michael Hughes

Principal Investigators

  • Amy Baker

  • Sue Farrington

  • John Pauling

Medical Centers

  • Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK

  • Engagement and Development, Scleroderma and Raynaud’s UK, London, UNITED KINGDOM

  • Chief Executive - SRUK, Scleroderma and Raynaud’s UK, London, UNITED KINGDOM

  • Department of Rheumatology, Royal National Hospital for Rheumatic Diseases NHS Foundation Trust, Bath, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Raynaud syndrome

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved